NCT01185847

A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Nowotwór
rak płuca
Chorzy
ALK+
Faza badania
II
Sponsor badania
Roche
Termin
-
Linki
www.clinicaltrials.gov
Dane kontaktowe
Łódź; Otwock